MDGL

MADRIGAL PHARMACEUTICALS, INC.

Next Earnings

—

Net Activity (1Y)

-$58.9M

Net Activity (90D)

-$5.2M

Insider Activity Graph

(126 shown · 173 raw)

Green/Red bubbles = daily net insider value (size = magnitude), Blue line = daily close price, E = earnings-related SEC filing

Insider trades for this company
Insider	Title	Type	Date ↓	Shares	Value
William John Sibold	President and CEO	Sale	2026-07-20	2,500	$1.4M
David Soergel	Chief Medical Officer	Sale	2026-06-01	1,042	$517K
Richard S Levy	—	Sale	2026-05-22	5,682	$2.9M
David Soergel	Chief Medical Officer	Sale	2026-05-18	844	$435K
Mardi Dier	EVP and CFO	Sale	2026-03-06	1,982	$854K
William John Sibold	President and CEO	Sale	2026-03-06	1,663	$718K
Shannon T Kelley	General Counsel	Sale	2026-03-06	360	$155K
Carole Huntsman	Chief Commercial Officer	Sale	2026-03-06	419	$181K
Rebecca Taub	—	Sale	2026-03-06	491	$212K
Mardi Dier	EVP and CFO	Sale	2026-03-02	1,183	$505K
Carole Huntsman	Chief Commercial Officer	Sale	2026-01-26	910	$449K
William John Sibold	President and CEO	Sale	2026-01-26	1,577	$777K
Rebecca Taub	—	Sale	2026-01-26	647	$319K
Shannon T Kelley	General Counsel	Sale	2026-01-20	692	$344K
Rebecca Taub	—	Sale	2026-01-20	2,238	$1.1M
Paul A Friedman	—	Sale	2026-01-09	24,800	$13.0M
Rebecca Taub	—	Sale	2026-01-09	18,650	$9.7M
Paul A Friedman	—	Sale	2025-12-10	24,800	$13.7M
Rebecca Taub	—	Sale	2025-12-10	18,650	$10.3M
William John Sibold	President and CEO	Sale	2025-12-04	2,400	$1.4M